SymKardia raises $12M for health care technology in Ohio
Sold rose to $NaN (+$3.8M, +2 investors) in 132 days since the previous filing.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2026-06-18 | D | $500K | 1 | |
| 2026-10-28 | D/A | $4.3M | 3 | +$3.8M |
| 2026-10-28 | D | $4M | 8 | −$300K |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor.
Sold rose to $NaN (+$3.8M, +2 investors) in 132 days since the previous filing.
| Robert Picarel | Director |
| Steven Girouard | Executive Officer |
| Claudio Rumazza | Director |
| Jonathan Piccini | Executive Officer |
| Dwight Skinner | Executive Officer |
| Imad Libbus | Executive Officer |
| Arun Sridhar | Director |
| Bruce KenKnight | Executive Officer |
| Anthony Caparso | Executive Officer, Director |
| Alain Garcinuno Collet | Director |
| James Blouzard | Director |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Anthony Caparso, President.
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO.
The issuer's phone number and address from the filing are shown to subscribers. See plans.